We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
-16.26%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
-$2.13B
(-15%)
Cap. Flow
+$457M
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
9.66%
Holding
494
New
75
Increased
149
Reduced
153
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$102M |
| 2 |
AGNC Investment
AGNC
|
+$72.1M |
| 3 |
Mid-America Apartment Communities
MAA
|
+$67.5M |
| 4 |
Constellation Brands
STZ
|
+$66.9M |
| 5 |
Diamondback Energy
FANG
|
+$57.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTRI
NutriSystem, Inc.
NTRI
|
+$72.5M |
| 2 |
Texas Capital Bancshares
TCBI
|
+$61.7M |
| 3 |
Electronic Arts
EA
|
+$48.9M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$47.2M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.05% |
| 2 | Technology | 17.64% |
| 3 | Industrials | 14.71% |
| 4 | Consumer Discretionary | 13.8% |
| 5 | Financials | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Bloom Energy
BE
$63B
| $10.2M | 0.09% |
1,026,442
+388,850
| +61% | +$7.51M |
|
302
SAP
SAP
$208B
| $10.2M | 0.09% |
102,341
-3,236
| -3% | -$344K |
|
|
WAGE
303
DELISTED
WageWorks, Inc.
WAGE
| $10M | 0.08% |
368,864
-84,233
| -19% | -$3.03M |
|
304
The GEO Group
GEO
$4.15B
| $9.99M | 0.08% |
506,951
-156,625
| -24% | -$3.55M |
|
305
Vulcan Materials
VMC
$35.3B
| $9.84M | 0.08% |
99,575
+8,225
| +9% | +$834K |
|
306
Hartford Financial Services
HIG
$39.1B
| $9.8M | 0.08% |
220,375
-167,500
| -43% | -$7.54M |
|
307
Hormel Foods
HRL
$13.8B
| $9.72M | 0.08% |
227,825
-28,950
| -11% | -$1.25M |
|
308
Lincoln National
LNC
$8.63B
| $9.67M | 0.08% |
188,500
-196,075
| -51% | -$11.9M |
|
309
Grupo Cibest SA
CIB
$22B
| $9.61M | 0.08% |
252,227
-94,763
| -27% | -$3.79M |
|
310
Enbridge
ENB
$120B
| $9.6M | 0.08% |
308,840
-57,502
| -16% | -$1.85M |
|
311
Ralph Lauren
RL
$22.9B
| $9.55M | 0.08% |
92,350
+9,225
| +11% | +$1.09M |
|
312
Teleflex
TFX
$5.82B
| $9.49M | 0.08% |
36,700
-51,650
| -58% | -$13.1M |
|
313
Texas Roadhouse
TXRH
$13.6B
| $9.35M | 0.08% |
156,644
-36,525
| -19% | -$2.35M |
|
314
Arch Capital
ACGL
$34.3B
| $9.29M | 0.08% |
347,750
+41,225
| +13% | +$1.14M |
|
315
Southwest Airlines
LUV
$22.1B
| $9.1M | 0.08% |
195,775
-148,525
| -43% | -$7.89M |
|
316
Jack Henry & Associates
JKHY
$10.8B
| $8.92M | 0.08% |
70,500
-40,575
| -37% | -$5.76M |
|
317
Adobe
ADBE
$97B
| $8.8M | 0.07% |
+38,900
| New | +$9.39M |
|
318
Clorox
CLX
$11.5B
| $8.76M | 0.07% |
56,800
-60,700
| -52% | -$9.46M |
|
319
Boeing
BA
$168B
| $8.58M | 0.07% |
+26,600
| New | +$9.19M |
|
320
Kirby Corp
KEX
$7.13B
| $8.31M | 0.07% |
+123,400
| New | +$9.13M |
|
321
Camden Property Trust
CPT
$10.9B
| $8.16M | 0.07% |
92,719
+6,819
| +8% | +$625K |
|
322
Amgen
AMGN
$206B
| $8.04M | 0.07% |
+41,300
| New | +$8.06M |
|
323
Humana
HUM
$44.4B
| $7.78M | 0.07% |
27,160
| – | – |
|
324
Match Group
MTCH
$9.12B
| $7.72M | 0.07% |
180,475
+8,925
| +5% | +$410K |
|
325
Teledyne Technologies
TDY
$30.2B
| $7.48M | 0.06% |
36,139
-3,200
| -8% | -$700K |
|
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, Carillon Tower Advisers held 494 positions worth $11.8B, down 15% from $13.9B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Carillon Tower Advisers deployed $457M of net new capital in Q4 2018, opening 75 new positions and adding to 149 existing holdings. Its largest new stake was AGNC Investment: 4,047,600 shares worth $71M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Abiomed Inc, an estimated $46M trimmed.
- Carillon Tower Advisers's largest Q4 2018 buy was AGNC Investment: 4,047,600 shares worth $71M.
- Carillon Tower Advisers added most to Centene in Q4 2018, an estimated $102M increase.
- Carillon Tower Advisers's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $46M.
- Carillon Tower Advisers fully exited NutriSystem, Inc. in Q4 2018, selling an estimated $72.5M.
- Carillon Tower Advisers's ten largest holdings make up 9.7% of its $11.8B portfolio in Q4 2018.
- Carillon Tower Advisers opened 75 new positions and closed 37 in Q4 2018.
- Carillon Tower Advisers's portfolio value fell 15% quarter-over-quarter to $11.8B.
Based on Carillon Tower Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.